ImmunoVEX HSV2

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameImmunoVEX HSV2

Drug Alias NameHerpes simplex virus vaccine (Amgen)Genital herpes vaccine (Amgen)

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHerpes Simplex

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesAmgen Inc

Inactive CompaniesN/A

Active IndicationsHerpes Simplex

Inactive IndicationsN/A

ATC CodeN/A